Jianhong Peng

14PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 05, 2026
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation.

Weihao Li, Jianhong Peng, Jiahua He

|Aug 21, 2025
Prognostic significance of DNA ploidy, stroma fraction, and nucleotyping in stage IIIb colon cancer and their implications for adjuvant chemotherapy.

Weili Zhang, Yuxin Gu, Xiajuan Xue

|Jun 30, 2025
circNRIP1 impairs tumorigenesis of colorectal cancer by sponging IGF2BP1 and decreasing NACC1 mRNA stability.

Kai Han, Qiaoqi Sui, Yanbo Xu

|Jun 23, 2025
Neoadjuvant rectal-tumor regression grade combined score as surrogate endpoint for disease-free survival in locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy.

Weili Zhang, Hui Sun, Rong Yang

|Jun 19, 2024
Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer.

Jianhong Peng, Weili Zhang, Jiahua He

|Apr 25, 2022
Conversion therapy with the intent to perform radical local treatment may not be suitable for patients with 10 or more liver metastases from colorectal cancer.

Junzhong Lin, Hui Sun, Weili Zhang

Pageof 3

Frequent Collaborators

5 joint publications

Weili Zhang

3 joint publications

Weihao Li

2 joint publications

Binyi Xiao

1 joint publications

Ji-Bin Li